Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease.
Suzuki T, Kohno H, Hasegawa A, Toshima S, Amaki T, Kurabayashi M, Nagai R, Suzuki T, Amaki T, Nagai R, Hasegawa A, Toshima S, Kurabayashi MH, Shimada K, Nakamura H, Teramoto T, Yamaguchi H, Nishiyama S, Takahashi H, Michishita I, Sugano Z, Konoshi K; Clinical Trial of Oxidized LDL (CTOL) investigators.
Suzuki T, et al.
Clin Biochem. 2002 Jul;35(5):347-53. doi: 10.1016/s0009-9120(02)00326-0.
Clin Biochem. 2002.
PMID: 12270763